The Business & Technology Network
Helping Business Interpret and Use Technology
«  
  »
S M T W T F S
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29
 
30
 
31
 
 
 
 
 

Feed Items

Isara, a San Francisco startup that is building software to coordinate thousands of AI agents on complex analytical tasks, has raised $94 million at a $650 million valuation, with OpenAI among the investors. The company was founded nine months ago by two 23-year-olds. It has no product in market. The round was first reported by […] This story continues at The Next Web
Spain’s largest life sciences VC is moving upstream with InceptionBio, its first fund dedicated to the riskiest stage of biotech: company creation from university and research centre spinouts. CDTI is an anchor LP. The target is at least three new companies in 2026. The hardest part of turning academic science into a biotech company is […] This story continues at The Next Web
The Dutch biotech’s SureTACs platform targets membrane proteins that have long eluded conventional drug discovery by engineering them out of existence rather than blocking them. Biovance Capital joins as new co-lead alongside Kurma Partners in a final close that brings the oversubscribed seed round to €17 million. Most drugs work by blocking proteins. They attach […] This story continues at The...
The Munich startup’s demo plant at Chemical Park Gendorf in Bavaria processes 1,500 tonnes of battery waste a year and produces 100 tonnes of high-purity lithium carbonate, at costs the company says are twice as competitive as conventional miners. A full-scale facility capable of 45,000 tonnes per year is planned for 2030. Europe has a […] This story continues at The Next Web
OpenAI has shelved its plans to add an erotic “adult mode” to ChatGPT indefinitely, the Financial Times reported on Wednesday, capping a five-month saga in which the feature was announced with confidence, delayed twice, and ultimately abandoned after pushback from staff, advisors, and investors. The retreat is the third major product reversal for OpenAI in […] This story continues at The Next Web
Blossom Health, a New York-based telepsychiatry startup founded in 2024, has raised $20 million in combined seed and Series A funding to scale an AI-powered platform that pairs psychiatrists with clinical copilots and automated administrative support. The round was led by Headline, whose co-founder and managing partner Mathias Schilling is joining the company’s board. Village […] This story...
Most organizations are not failing at AI because of technology. They are failing because they do not know which data actually matters, and they are scaling that confusion faster than ever. At a time when investment continues to surge, the expectation is that more intelligence will naturally follow. Instead, many teams are finding themselves overwhelmed. […] This story continues at The Next Web
Xero, the New Zealand-founded accounting platform used by 4.6 million subscribers worldwide, announced on Wednesday a multi-year partnership with Anthropic that will embed Claude directly into its product and, more unusually, bring Xero’s financial data into Claude.ai itself. The deal means small business owners will be able to ask Claude questions about their cash flow, […] This story continues...
Shield AI, the San Diego defence technology company behind the autonomous pilot system Hivemind, announced on Wednesday that it has raised $2 billion in combined funding at a $12.7 billion valuation. The company will use part of the proceeds to acquire Aechelon Technology, a simulation platform that supports the Pentagon’s Joint Simulation Environment. The raise […] This story continues at The...
If you have ever spent weeks preparing for a compliance audit, manually collecting evidence across spreadsheets, chasing colleagues for policy sign-offs, and wondering whether your controls actually hold up under scrutiny, you already know the problem. Compliance is necessary. The way most companies do it is not. This article contains affiliate links. If you make […] This story continues at The...